Cargando…

The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series

CNS lymphoma often presents with atypical imaging characteristics leading to delay in diagnosis and initiation of treatment. Among the most rarely reported of these is entirely nonenhancing CNS lymphoma, which is estimated at an incidence of about 1%. Here, we present three cases of nonenhancing CNS...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowden, Stephen G, Munger, Daniel N, Thiessen, Jaclyn, Woll, S Cody Schoettler, Han, Seunggu J, Neuwelt, Edward A, Barajas, Ramon F, Ambady, Prakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962175/
https://www.ncbi.nlm.nih.gov/pubmed/33322942
http://dx.doi.org/10.2217/cns-2020-0020
_version_ 1783665417504423936
author Bowden, Stephen G
Munger, Daniel N
Thiessen, Jaclyn
Woll, S Cody Schoettler
Han, Seunggu J
Neuwelt, Edward A
Barajas, Ramon F
Ambady, Prakash
author_facet Bowden, Stephen G
Munger, Daniel N
Thiessen, Jaclyn
Woll, S Cody Schoettler
Han, Seunggu J
Neuwelt, Edward A
Barajas, Ramon F
Ambady, Prakash
author_sort Bowden, Stephen G
collection PubMed
description CNS lymphoma often presents with atypical imaging characteristics leading to delay in diagnosis and initiation of treatment. Among the most rarely reported of these is entirely nonenhancing CNS lymphoma, which is estimated at an incidence of about 1%. Here, we present three cases of nonenhancing CNS lymphoma in immune competent patients at both initial presentation and recurrence and in primary as well as secondary CNS lymphoma. Diffusion- and perfusion-weighted imaging was found helpful in diagnosis in some cases.
format Online
Article
Text
id pubmed-7962175
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-79621752021-03-19 The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series Bowden, Stephen G Munger, Daniel N Thiessen, Jaclyn Woll, S Cody Schoettler Han, Seunggu J Neuwelt, Edward A Barajas, Ramon F Ambady, Prakash CNS Oncol Case Series CNS lymphoma often presents with atypical imaging characteristics leading to delay in diagnosis and initiation of treatment. Among the most rarely reported of these is entirely nonenhancing CNS lymphoma, which is estimated at an incidence of about 1%. Here, we present three cases of nonenhancing CNS lymphoma in immune competent patients at both initial presentation and recurrence and in primary as well as secondary CNS lymphoma. Diffusion- and perfusion-weighted imaging was found helpful in diagnosis in some cases. Future Medicine Ltd 2020-12-16 /pmc/articles/PMC7962175/ /pubmed/33322942 http://dx.doi.org/10.2217/cns-2020-0020 Text en © 2020 Prakash Ambady This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Case Series
Bowden, Stephen G
Munger, Daniel N
Thiessen, Jaclyn
Woll, S Cody Schoettler
Han, Seunggu J
Neuwelt, Edward A
Barajas, Ramon F
Ambady, Prakash
The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series
title The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series
title_full The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series
title_fullStr The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series
title_full_unstemmed The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series
title_short The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series
title_sort clinical heterogeneity of entirely nonenhancing cns lymphoma: a case series
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962175/
https://www.ncbi.nlm.nih.gov/pubmed/33322942
http://dx.doi.org/10.2217/cns-2020-0020
work_keys_str_mv AT bowdenstepheng theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries
AT mungerdanieln theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries
AT thiessenjaclyn theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries
AT wollscodyschoettler theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries
AT hanseungguj theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries
AT neuweltedwarda theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries
AT barajasramonf theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries
AT ambadyprakash theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries
AT bowdenstepheng clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries
AT mungerdanieln clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries
AT thiessenjaclyn clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries
AT wollscodyschoettler clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries
AT hanseungguj clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries
AT neuweltedwarda clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries
AT barajasramonf clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries
AT ambadyprakash clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries